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Abstract
Results of studies on the role of the 18 kDa (IP) polypeptide subunit of complex I, encoded by the nuclear NDUFS4 gene, in isolated
bovine heart mitochondria and human and murine cell cultures are presented.The mammalian 18 kDa subunit has in the carboxy-terminal
sequence a conserved consensus site (RVS), which in isolated mitochondria is phosphorylated by cAMP-dependent protein kinase (PKA).
The catalytic and regulatory subunits of PKA have been directly immunodetected in the inner membrane/matrix fraction of mammalian
mitochondria. In the mitochondrial inner membrane a PP2Cg-type phosphatase has also been immunodetected, which dephosphorylates the
18 kDa subunit, phosphorylated by PKA. This phosphatase is Mg2 + -dependent and inhibited by Ca2 + . In human and murine fibroblast and
myoblast cultures ‘‘in vivo’’, elevation of intracellular cAMP level promotes phosphorylation of the 18 kDa subunit and stimulates the
activity of complex I and NAD-linked mitochondrial respiration.Four families have been found with different mutations in the cDNA of the
NDUFS4 gene. These mutations, transmitted by autosomal recessive inheritance, were associated in homozygous children with fatal
neurological syndrome. All these mutations destroyed the phosphorylation consensus site in the C terminus of the 18 kDa subunit, abolished
cAMP activation of complex I and impaired its normal assembly.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
A key feature of cellular metabolism is represented by its
complex regulation by a variety of factors. This can be
effected by modulation of transcription, translation, post-
translational modification, membrane traffic and assembly
of enzymes and carrier proteins.
Ultimately the activity of mature proteins can be modu-
lated ‘‘in situ’’ by covalent modification of the proteins or
by conformational changes in response to specific ligands.
All this is of particular importance in mammalian tissues
which have to adapt the rate of metabolic processes to
continuous changes in their activity under different physi-
opathological conditions.
In mammalian tissues the respiratory chain complexes
have a large number of supernumerary subunits, as com-
pared to prokaryotes and lower eukaryotes, which if not
necessary for the primary catalytic process can contribute to
confer them large regulatory flexibility [1]. Studies on the
relative activities and capacity reserves of the respiratory
chain complexes, in isolated mitochondria and cell cultures,
show these to vary considerably from tissue to tissue as well
as in different cell lines [1,2]. Changes in the activities of
redox complexes in the same tissue or cell lines in different
physiopathological conditions and/or in response to bio-
logical effectors have been reported [1,3].
The present paper summarizes the results of studies from
our group on the phosphorylation by cAMP-dependent
protein kinase (PKA) of the 18 kDa (IP) subunit of complex
I, encoded by the nuclear gene NDUFS4, the functional
impact of this process and the involvement of this subunit in
the assembly of complex I.
2. The 18 kDa (IP), NDUFS4-encoded subunit of
complex I
In mammalian mitochondria, complex I catalyses the
oxidation of NADH by ubiquinone and conserves the free
energy so made available as transmembrane proton-motive
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force (PMF). The reaction mechanism of the complex, the
functional role of its numerous constituent subunits [4] and
the biogenesis are still poorly understood [5]. Complex I
represents, at least under certain conditions, the rate-limiting
step of the overall respiratory activity in mitochondria
(Table 1). Complex I deficiency represents one of the most
severe and frequent of the disorders in the mitochondrial
energy metabolism associated with human diseases [11,12].
The complex consists of 43 subunits [4,13]. Seven
subunits (ND1–ND6 and ND4L) are encoded by the
mitochondrial genome; the others are encoded by nuclear
genes. The cDNA of the seven mitochondrial subunits [14]
and of 35 nuclear subunits [15,16] have been sequenced.
The function of only few of the subunits of complex I has so
far been identified [4]. Besides the six subunits which
appear to be involved in redox functions, the SDAP 10
kDa subunit, sharing homology with acyl carrier proteins
[17], appears to be involved in mitochondrial phospholipid
metabolism. Evidence that the 24 kDa subunit is a G protein
has also been presented [18].
The 18 kDa (IP) subunit [4] is encoded by the nuclear
NDUFS4 gene [19]. It consists of 175 amino acids, which
appear to be highly conserved in the known mammalian
sequences [4,19,20]. The mature form of 133 aminoacids
has at the carboxy-terminal position 129–131 a conserved
cAMP-dependent protein kinase phosphorylation consensus
site (RVS) [21]. The protein has a leader sequence, removed
after import into mitochondria [4], that also contains a
phosphorylation consensus site (RTS in the human protein,
at position  7  5). The leader sequence has a number of
positively charged and hydroxylated residues which are
characteristic of import signals of nuclear encoded subunits
of oxidative phosphorylation complexes [22].
The human NDUFS4 gene, coding for the 18 kDa (IP)
subunit of complex I, is localised at position 5q11.1 of
chromosome 5 [19]. The Blast search reveals five exons with
100% identity with the cDNA of the gene, which are
intercalated by four large introns [GENBANK] (Fig. 1). The
first exon is preceded by a short 5VUTR. The promoter re-
gion presents a 400-bp segment which shares 95% homol-
ogy with the promoter of the mouse gene. The overall size
of the human NDUFS4 gene amounts to 127 kb, showing
this to be a relatively large gene. In the conserved segment of
the promoter nucleotide sites for the transcription factors
NRF2, myoD and YYI are localised. Investigations are being
carried in collaboration with Richard Scarpulla of the North-
Table 1
Relative activities and inhibition thresholds of respiratory chain complexes in isolated mitochondria and human and murine cell cultures
Activities of complexes
nequivalentse min 1mg prot 1
I– III III IV III/I– III IV/I– III IV/III Refs.
Human skeletal muscle mitochondria Males 228 420 739 1.84 3.24 1.76 [6]
Females 223 586 729 2.63 3.27 1.24
fmoles (NADH) or fatoms Omin 1cell 1
I IV IV/I
Mouse fibroblasts 4.85 9.40 1.94 [7]
Human fibroblasts 2.39 9.87 4.13 [8]
Mouse myoblasts 7.75 13.09 1.68 [9]
Inhibition tresholds
I III IV
Synaptic Mitochondria 25% 80% 70% [10]
Fig. 1. Structure of the human NDUFS4 gene coding for the 18 kDa (IP)
subunit of complex I (NADH-ubiquinone oxidoreductase) of the mitochon-
drial respiratory chain.
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western University in Chicago in order to better characterise
the promoter region of the gene and its regulation.
3. cAMP-dependent phosphorylation and
dephosphorylation of the 18 kDa subunit in
mitochondria
In bovine heart mitochondria, the addition of cAMP or
dibutyryl-cAMP results in the phosphorylation of protein
bands of 29, 18 and 6.5 kDa, respectively [23]. In intact
mitochondria, the cAMP-dependent phosphorylation of
these proteins by [g-32P]ATP is inhibited by carboxyactrac-
tyloside [24], showing that both the catalytic site of PKA
and the mitochondrial proteins phosphorylated are localized
at the matrix side of the inner mitochondrial membrane.
Separation of the five complexes of oxidative phosphor-
ylation by blue-native electrophoresis of the inner mem-
brane fraction of bovine heart mitochondria and mouse
myoblasts, incubated with [g-32P]ATP, followed by SDS-
PAGE of the individual complexes, has shown that cAMP
promotes 32P labelling of the 18 kDa protein band of
complex I (Fig. 2) [25,9]. Furthermore, it was found that
the purified catalytic subunit of PKA catalysed, in the
presence of [g-32P]ATP, 32P labelling of the 18 kDa
(AQDQ, NH2-terminus) subunit of the purified complex I
from bovine heart mitochondria [26].
The presence of PKA in mitochondria has been directly
demonstrated by immunoblot analysis, which revealed the
presence of both the regulatory R-II type and catalytic
subunit in the mitochondrial inner-membrane matrix frac-
tion of bovine heart and mouse myoblasts (Fig. 3A) [9]. In
the inner membrane and matrix fraction, serine/threonine
phosphatases of the PP2Cg type were also immunodetected
(Fig. 3B) [27]. Activity tests showed that the 18 kDa subunit
of complex I, previously phosphorylated by PKA, was
Fig. 2. Two dimensional electrophoretic pattern of protein labelling by [g-32P]ATP in oxidative phosphorylation complexes from bovine heart mitochondria
separated by blue-native electrophoresis and resolved in their subunits by SDS-PAGE (reproduced from Ref. [24]). The 42-kDa 32P-labelled protein was
loosely associated to the complexes [24] (panel a). Immunodetection of phosphoserine in oxidative phosphorylation complexes separated by two-dimensional
Blu-native SDS-PAGE of mitoplasts from control and cholera-toxin-treated C2C12 mouse myoblasts to enhance the intracellular concentration of cAMP
(reproduced from Ref. [9]).
Fig. 3. Localization of PKA and PP2C type phosphatase in mitochondria. Localization of PKA (A) (from Ref. [9]) and PP2C (B) (from Ref. [27]) by
immunoblot analysis with polyclonal antibodies against the regulatory (RII-PKA) and catalytic (C-PKA) subunits of PKA and with monoclonal antibody
against PP2C in subcellular fractions of bovine heart (BH) and cultured C2C12 mouse myoblasts.
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dephosphorylated by both the membrane and matrix phos-
phatase. Dephosphorylation of the 18 kDa protein by the
inner membrane phosphatase was activated by Mg2 + and
inhibited by Ca2 + , in the same concentration range at which
this cation activated the pyruvate dehydrogenase phospha-
tase (Fig. 4) [27].
These observations clearly demonstrate the occurrence in
the inner membrane matrix of cAMP-dependent reversible
phosphorylation of mitochondrial proteins. Although the
main pool of PKA is known to be localized in the cytosol,
this enzyme is also found in other subcellular compartments
[21]. An important breakthrough in understanding the intra-
cellular distribution of PKA was provided by the discovery
of a new family of proteins (protein kinase A anchor
proteins, AKAP), which specifically anchor PKA to differ-
Fig. 4. Effect of Ca2 + on dephosphorylation of mitochondrial phospho-
proteins. (A) The 18 kDa subunit of purified complex I was phosphorylated
by the catalytic subunit of PKA (cPKA) with [g 32P]ATP. Dephosphor-
ylation was measured by incubation of the 32P-labelled subunit in complex I
with cold inner-membrane fraction of bovine heart mitochondria in the
presence of 4 mM MgCl2 and CaCl2 at the concentrations indicated in the
figure. (B) For dephosphorylation of the 42 kDa 32P-labelled protein (a-
subunit of pyruvate dehydrogenase) the inner-membrane fraction was
preincubated with [g 32P]ATP and cPKA. Inhibitor of PKA was then
added and dephosphorylation of the phosphoprotein was measured in the
absence or presence of CaCl2 (compiled from data in Ref. [27]).
Fig. 5. cAMP-dependent phosphorylation of the 18 kDa subunit of complex
I and its impact on the activity of the complex and mitochondrial respiration
in mouse-fibroblast cultures (reproduced from Ref. [7]). 3T3 mouse
fibroblasts were cultivated under serum starvation conditions in the absence
or in the presence of cholera toxin. Panel a: immunodetection of
phosphoserine-containing, proteins and of the 24 kDa subunit of complex
I in mitoplasts from fibroblasts and in solubilized proteins immunopreci-
pitated from mitoplasts with an antibody against the 75 kDa subunit of
complex I. Panel b: respiratory activities of serum starved and cholera-toxin
treated fibroblasts. Panel c: Vmax of complex I in serum-starved and
cholera-toxin-treated fibroblasts (for details see Ref. [7]).
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ent cellular structures [28,29]. Mammalian mitochondrial
AKAPs which bind both RI and RII isoforms have been
identified, D-AKAP1 [30] and D-AKAP2 [31]. Alternative
N-terminus splice variants seem to control the direction of
D-AKAP1 either to mitochondria or endoplasmic reticulum
[30]. D-AKAP2 has a positively charged N terminus which
might serve for its preferential localization in mitochondria
[31]. It has been shown that AKAP protein can form
supercomplexes containing, PKA, phosphatases and their
substrates [32].
4. cAMP-dependent phosphorylation of the 18 kDa
subunit of complex I and activation of the complex in cell
cultures in vivo
Whilst mitochondrially encoded proteins can only be
phosphorylated by mtPKA, nuclear encoded proteins can
first be phosphorylated in the cytosol, where the major pool
of PKA is localized, and then imported in mitochondria
where they can also be phosphorylated. These aspects were
investigated in primary cultures of various mammalian cell
lines. Intracellular ‘‘in vivo’’ elevation of the level of cAMP
in cultures of mouse fibroblasts, effected by the addition of
cholera toxin, which induces permanent activation of adeny-
late kinase, promoted phosphorylation of the 18 kDa subunit
of complex I (Fig. 5) [7]. This was accompanied by
stimulation of the rotenone-sensitive activity of complex I
and activation of the overall NAD-linked mitochondrial
respiratory activity (Fig. 5) [7].
A short-term stimulatory effect on complex I activity and
NAD-linked respiration, although smaller than that
observed in intact cells, was also produce by incubation
with dibutyryl-cAMP of mitoplasts isolated from starved
fibroblasts [7].
The same observations have been made on human
fibroblasts [8] and mouse myoblast cultures [9]. Thus,
phosphorylation of the 18 kDa subunit by PKA regulates
the activity and possibly also the biogenesis of complex I.
Through this effect, a rise in the cellular level of cAMP can
result in activation of mitochondrial respiration.
5. NDUFS4 mutations associated with pathological
deficiency of complex I
Recently, four families have been found with different
mutations in the cDNA of the NDUFS4 gene [19,33–35].
These mutations were transmitted by autosomal recessive
inheritance and children homozygous for the mutations
were affected by a fatal neurological syndrome. The first
of these mutations, identified by van den Heuvel et al. [19],
consisted of a 5-bp duplication in the cDNA at po-
Fig. 6. Functional defects of complex I associated with homozygous
mutations of the NDUFS4 gene (18 kDa subunit) in children, affected by
fatal neurological syndrome. The specific activity (Vmax) of complex I was
determined in the mitoplast fraction isolated from serum-starved and
cholera-toxin-treated control and patient fibroblasts (compiled from Refs.
[8,34]).
Fig. 7. Blue-native SDS-PAGE two-dimensional gel separating the
constituent subunits of oxidative phosphorylation complexes of the
mitoplast fraction (inner-membrane plus matrix) of human fibroblasts from
a control subject and a child with homozygous non-sense G!A transition
at nucleotide + 44 of cDNA of the NDUFS4 gene. (A) Silver staining of the
gel. (B) Immunodetection with specific polyclonal antibodies for the a/h
subunit of complex V–F1, serine-phosphorylated carboxy-terminus of the
18 kDa subunit and B13 subunit of complex I (for details see Refs. [8,34]).
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sition 466–470 (AAGTC), with destruction of the phos-
phorylation consensus site and elongation of the C termi-
nus of the 18 kDa subunit of complex I. The other two,
consisting of point mutations, caused in the homozygous
patients premature translation stop, resulting in truncated
proteins with destruction of the phosphorylation site in the
C-terminal region [33]. A fourth mutation, identified by our
group, consisted of a G-to-A transition, changing a trypto-
phan codon (TGG) to a stop codon (TAG) with premature
termination of the protein after only 14 amino acids of the
putative mitochondrial targeting sequence [34]. Results
from investigations on skin fibroblast cultures from the
patient showed that the 5-bp duplication abolished cAMP-
dependent phosphorylation of the 18 kDa subunit of
complex I, cAMP activation of the normal rotenone-sensi-
tive NADH-UQ oxidoreductase activity of the complex
(Fig. 6) and of NAD-linked respiratory activity [8].
Analysis of skin fibroblasts from the patient with nonsense
mutation of the NDUFS4 gene showed this to result in
complete suppression of the rotenone-sensitive NADH-UQ
oxidoreductase activity of the complex both in the absence
and presence of cholera-toxin induced cAMP production
(Fig. 6) [34]. Two-dimensional native/SDS-PAGE electro-
phoresis showed that the nonsense mutation was associated
with defective assembly of the complex, with appearance of a
nonfunctional lower molecular weight subcomplex [34] (Fig.
7).More recent work in our laboratory has shown that also the
other reported mutations of the NDUFS4 gene prevented the
normal assembly of the mature complex, with appearance of
immature lower molecular weight subcomplex.
6. Conclusions
cAMP-dependent phosphorylation of the 18 kDa subunit
is associated with potent stimulation of complex I. The 18-
kDa phosphoprotein is dephosphorylated by a Mg2 + -
dependent phosphatase, which is inhibited by Ca2 + at the
same concentrations at which this cation stimulates the
pyruvate dehydrogenase phosphatase (Fig. 4) and activates
the dehydrogenase [36]. In this way, Ca2 + can exert two
convergent stimulatory effects on NAD-linked respiration in
mitochondria. It is worth noting that mitochondrial Ca2 +
concentrations of 10 5–10 4 M, effective on both phos-
phatases, have been directly measured ‘‘in vivo’’ with a
fluorescent recombinant probe [37]. The cAMP activation
of complex I was missing in fibroblasts of patients affected
by fatal neurological syndrome, in which mutation in the
NDUFS4 gene destroying the phosphorylation consensus
site in the 18-kDa protein had been identified. All the above
shows that the cAMP- and Ca2 + -dependent phosphoryla-
tion-state of the protein encoded by the NDUFS4 gene
regulates the activity of complex I and NAD-linked mito-
chondrial respiration. Since the cAMP cascade mediates the
action of a variety of cellular effectors, regulation of
mitochondrial respiration by cAMP appears to be a major
control factor in the bioenergetic function of mammalian
tissues. All the mutations so far identified in the NDUFS4
gene were associated with impaired formation of a normal
complex I. This gene thus appears essential not only for
regulation of the activity of the complex by the cAMP
cascade but also for its assembly in the inner mitochondrial
membrane. Further investigations should elucidate the reg-
ulation of the expression of the NDUFS4, the mechanism by
which the NDUFS4 is involved in the assembly of the
complex in mammalian cells and the mechanism of regu-
lation of complex I by the cAMP-dependent phosphoryla-
tion of the 18 kDa subunit.
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